EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Overview Fund Activity
Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

151 hedge funds and large institutions have $659M invested in Eagle Pharmaceuticals, Inc. in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 43 increasing their positions, 62 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
151
Holders Change
+5
Holders Change %
+3.42%
% of All Funds
2.65%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
15
Increased
43
Reduced
62
Closed
9
Calls
$1.63M
Puts
–
Net Calls
+$1.63M
Net Calls Change
+$1.63M

Top Buyers

1
Balyasny Asset Management
Balyasny Asset Management
Illinois
$9.22M
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
$13.2M
3
Wells Fargo
Wells Fargo
California
$14.7M
4
SDIC
South Dakota Investment Council
South Dakota
$6.11M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
$2.4M

Top Sellers

1
Invesco
Invesco
Georgia
$3.89M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
$7.21M
3
Goldman Sachs
Goldman Sachs
New York
$5.97M
4
Millennium Management
Millennium Management
New York
$767K
5
BIP
Brandes Investment Partners
California
$37.5M
Name Holding Trade Value Shares
Change 		Shares
Change %
Nisa Investment Advisors
151
Nisa Investment Advisors
Missouri
$169 -$80 -1,437 -32%
Pacer Advisors
152
Pacer Advisors
Pennsylvania
– -$1.09M -25,434 Closed
ETC
153
Exchange Traded Concepts
Oklahoma
– -$980K -22,897 Closed
EGM
154
Engineers Gate Manager
New York
– -$429K -10,034 Closed
6M
155
6 Meridian
Kansas
– -$349K -8,157 Closed
JF
156
Jump Financial
Illinois
– -$282K -6,600 Closed
ZCM
157
Zebra Capital Management
Connecticut
– -$277K -6,472 Closed
Squarepoint
158
Squarepoint
New York
– -$222K -5,197 Closed
HTC
159
Hershey Trust Company
Pennsylvania
– -$92K -2,138 Closed
3 4 5 6
7